Soluble-fibre concentrate lowers plasminogen activator inhibitor-1 in baboons (Papio ursinus)

The effects of a soluble NSP (fibre) concentrate (SFC) on plasma fibrinogen and plasminogen activator inhibitor-1 (PAI-1), serum and liver lipids and lipoproteins and glucose tolerance were compared with those of bezafibrate (BF), a lipid-lowering drug, in obese baboons (Papio ursinus) The basal die...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of nutrition 1997-10, Vol.78 (4), p.625-637
Hauptverfasser:	Venter, C. S., Nel, C. J., Vorster, H. H., Jerling, J. C., Oosthuizen, W., Veldman, F. J., Kellerman, J. A., Smuts, C. M., Vermaak, W. J. H., Van Der Nest, D. G., Ridder, J. H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis of Variance animal models Animals anticholesteremic agents Baboons Bezafibrate - therapeutic use Biological and medical sciences blood lipids blood serum concentrates Diet dietary fat dietary fiber Dietary Fiber - administration & dosage dietary supplements Diseases of the cardiovascular system enzyme inhibitors experimental diets General Nutrition Glucose - metabolism high density lipoprotein Hypolipidemic Agents - therapeutic use Lipid Metabolism Lipids - blood Lipoproteins - blood Liver - metabolism Male Medical sciences obesity Obesity - blood Obesity - drug therapy Obesity - therapy Papio Plasminogen Activator Inhibitor 1 - metabolism Plasminogen activator inhibitor-1 Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Random Allocation solubility Soluble-fibre concentrate triacylglycerols Triglycerides - blood Triglycerides - metabolism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!